SCHEMBL6639245

SCHEMBL6639245

O=c1[nH]c2cc(F)ncc2cc1-c1c(Cl)cccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 10/20 0.53
▸ SRC P12931 10/20 0.53
▸ CHEK1 O14757 1/20 0.43
▸ EGFR P00533 3/20 0.41
▸ FGFR2 P21802 1/20 0.41
▸ FGFR4 P22455 1/20 0.41
▸ FGFR3 P22607 1/20 0.41
▸ ABL1 P00519 3/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ PDGFRA P16234 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ GRIN2D O15399 1/20 0.40
▸ GRIN3B O60391 1/20 0.40
▸ GRIN1 Q05586 1/20 0.40
▸ GRIN2A Q12879 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40
▸ GRIN2C Q14957 1/20 0.40
▸ GRIN3A Q8TCU5 1/20 0.40
▸ PTGES O14684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17119637 0.80 CHEK1 (0.51) FGFR1SRCCHEK1FGFR4PTGES
SCHEMBL8142094 0.79 FGFR1 (0.55) FGFR1SRCCHEK1EGFRFGFR2
SCHEMBL10276720 0.79 FGFR1 (0.65) FGFR1SRCEGFRFGFR2FGFR4
SCHEMBL6643371 0.74 FGFR1 (0.43) FGFR1SRCCHEK1GRIN2DGRIN3B
SCHEMBL5619944 0.74 SRC (0.56) FGFR1SRCEGFRFGFR2FGFR4
SCHEMBL6640886 0.72 FGFR1 (0.73) FGFR1SRCEGFRFGFR2FGFR4
SCHEMBL8143371 0.72 FGFR1 (0.67) FGFR1SRCCHEK1EGFRFGFR2
SCHEMBL5659394 0.71 FGFR1 (0.45) FGFR1SRCEGFRFGFR2FGFR4
SCHEMBL29536840 0.71 FGFR1 (0.45) FGFR1SRCEGFRFGFR2FGFR4
SCHEMBL22538244 0.70 FGFR1 (0.47) FGFR1SRCCHEK1EGFRFGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003745-B1 NAPHTHYRIDINONES FOR INHIBITING PROTEIN TYROSINE KINASE AND CELL CYCLE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2004-12-29 — — EP disclosed
US-6150359-A 1,6-NAPHTHYRIDIONE COMPOUNDS USEFUL FOR TREATING CANCER, RESTENOSIS AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 2000-11-21 — — US disclosed
Send feedback